Tag Archives: Alabama Defense Lawyer

Two New HIV Treatments Gain Approval From FDA – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Two New HIV Treatments Gain Approval From FDA – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the FDA today approved Merck’s doravirine/lamivudine/tenofovir disoproxil fumarate (Delstrigo) tablet and … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Dozens of Drug Products Recalled Due to Microbial Contamination – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Dozens of Drug Products Recalled Due to Microbial Contamination – APhA submits compounding comments to FDA. – (866) 348-2889. The FDA is warning consumers not to use drug products, including homeopathic … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

One Lot of Children’s Advil Suspension Recalled – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF One Lot of Children’s Advil Suspension Recalled – APhA submits compounding comments to FDA. – (866) 348-2889. One lot of Children’s Advil® Suspension, Bubble Gum Flavored Liquid bottles (4 fluid ounces) … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

ARRIVE Trial: Daily Aspirin Did Not Lower First Heart Attack, Stroke Risk – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF ARRIVE Trial: Daily Aspirin Did Not Lower First Heart Attack, Stroke Risk – APhA submits compounding comments to FDA. – (866) 348-2889. Daily aspirin did not reduce the occurrence of major … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

HIV Therapy Effective in Reducing Virus in Multi-Drug Resistant Patients – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF HIV Therapy Effective in Reducing Virus in Multi-Drug Resistant Patients – APhA submits compounding comments to FDA. – (866) 348-2889. A new HIV therapy demonstrated its efficacy in reducing the virus … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Study: Older Adults, Hispanics Less Likely to Receive HIV Testing – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Study: Older Adults, Hispanics Less Likely to Receive HIV Testing – APhA submits compounding comments to FDA. – (866) 348-2889. Health care providers recommend routine HIV testing to individuals who … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Expert Panel: Opioid Prescribing Limits Should be Based on Operation Performed – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Expert Panel: Opioid Prescribing Limits Should be Based on Operation Performed – APhA submits compounding comments to FDA. – (866) 348-2889. An expert panel of health care providers and patients are … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Stroke in Infant Linked to Siblings’ Preventable Virus – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Stroke in Infant Linked to Siblings’ Preventable Virus – APhA submits compounding comments to FDA. – (866) 348-2889. The varicella zoster virus (VZV), more commonly known as chickenpox, is notorious for … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Medicaid Expansion Boosts Health Coverage Among Low-Income Patients With Substance Use Disorders – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Medicaid Expansion Boosts Health Coverage Among Low-Income Patients With Substance Use Disorders – APhA submits compounding comments to FDA. – (866) 348-2889. States that chose to expand Medicaid eligibility under the … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Grants Breakthrough Designation to Omalizumab for Food Allergies – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Grants Breakthrough Designation to Omalizumab for Food Allergies – APhA submits compounding comments to FDA. – (866) 348-2889. The FDA has granted Breakthrough Therapy designation to omalizumab (Xolair, Genentech), a … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off